Clinical trial of porous bioactive titanium for lumbar spine fusion

Clinical trial of porous bioactive titanium for lumbar spine fusion - Clinical trial of porous bioactive titanium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001448

Enrollment

Registered

2008-10-21

Start date

2008-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc disease, lumbar spondylolisthesis, lumbar isthmic spondylolisthesis

Interventions

Transforaminal lumbar interbody fusion

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Lumbar disc disease, spondylolisthesis, isthmic spondylolisthesis 2) Good general status

Exclusion criteria

Exclusion criteria: 1) No hip and leg disease 2) No cervical or thoracic spine disease 3) No previous lumbar spinal fusion 4) No collagen disease 5) BMI over 30 6) No pregnancy 7) No severe osteoporosis 8) No uncontrolable general disease 9) No malignacy 10) No psychological disease 11) No severe bacterial disease 12) No steroid treatment

Design outcomes

Primary

Measure	Time frame
Intraoperative handling of the implant and avoidance of iliac crest bone graft harvesting.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026